In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dr. Judy Garber commented on the increasing number of women who undergo genetic testing and then choose double mastectomies.

     

Tags: Genetics

  • Dana-Farber patient Grace Silva served as a case study of an “exceptional responder” for a treatment she underwent at the recommendation of her oncologists, Dr. Jochen Lorch and Dr. Nikhil Wagle.

     

Tags: BasicResearch

  • Dr. Judy Garber comments on Dana-Farber researchers using healthy breast tissue from high-risk patients to prevent breast cancer. 

     

Tags: BreastCancer

  • Dr. Brian Wolpin led a study showing an increase in certain metabolites in the blood could be a future noninvasive marker for pancreatic cancer.

Tags: PancreaticCancer

  • Dr. Rachel Freedman commented on targeted treatments – those that attack a specific characteristic of a cancer strain – becoming the norm in breast cancer care.

Tags: BreastCancer

  • Dr. Harold Burstein commented on a study of Perjeta, a drug used to treat advanced breast cancer that had unprecedented success in prolonging lives.

Tags: BreastCancer

  • Dr. Eric Winer served as chair for a panel that developed the second international guidelines for management of advanced breast cancer.

     

Tags: BreastCancer

  • Dr. Toni Choueiri led a study that found patients with non–clear cell renal cell carcinoma, PD-L1 positivity is associated with worse clinical outcomes, including a shorter overall survival and time to recurrence.

     

Tags: BasicResearch

  • Dr. Jay Harris proposed a breath-holding technique that reduces radiation to the heart during left-sided breast cancer treatment.

Tags: BreastCancer, Radiation

  • Dr. Harold Burstein commented on a study that found there was no evidence that surgery lowered the risk of death compared to more conservative lumpectomy and radiation.

     

Tags: GynecologicCancers

Showing 11-20 of 452 items